FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for treatment of bile passages dysfunction in children with acute intestinal infections. Used is medication Mebeverine, which is administered per os for one month after acute intestinal infection. Day dose of mebeverine constitutes for children from 3 to 4 years of age - 75 mg per day, for children from 4 to 8 years old - 150 mg per day, for children from 9 to 10 years - 300 mg per day, for children older than 10 years - 450 mg per day.
EFFECT: method makes it possible to normalise indices of bile bladder function and prevent possibilities of formation of its post-infection motility disorders.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS SUFFERING FROM FIRST STAGE CHOLELITHIASIS | 2012 |
|
RU2519198C2 |
| DIAGNOSTIC TECHNIQUE FOR FUNCTION-TYPE ODDI'S SPHINCTER DYSSYNERGIA FOLLOWING CHOLECYSTECTOMY | 2009 |
|
RU2416802C1 |
| METHOD OF PROPHYLAXIS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHOLELITHIASIS AFTER LAPAROSCOPIC CHOLECYSTECTOMY | 2017 |
|
RU2657838C1 |
| METHOD FOR BILIARY SLUDGE TREATMENT IN PATIENTS WITH CHRONIC BILIAR-DEPENDENT PANCREATITIS | 2016 |
|
RU2632443C1 |
| METHOD OF BILIARY DYSKINESIA TREATMENT | 2006 |
|
RU2329026C2 |
| METHOD FOR PREDICTIOM OF STRUCTURE OF COMMON BILE DUCT AND HEPATICOPANCREATIC AMPULLA STENOSIS IN PATIENTS AFTER CHOLECYSTECTOMY DUE TO CHOLELITHIASIS | 2016 |
|
RU2635962C1 |
| METHOD FOR TREATING DYSKINESIA OF BILIARY DUCTS IN SMALL CHILDREN | 2003 |
|
RU2245158C1 |
| METHOD FOR DIAGNOSTICS OF TYPE III ODDI'S SPHINCTER DYSFUNCTION IN PATIENTS OPERATED DUE TO CHOLELITHIASIS | 2016 |
|
RU2629396C1 |
| METHOD OF TREATMENT OF DYSFUNCTIONAL DISORDERS OF BILIARY SYSTEM AT CHILDREN | 2007 |
|
RU2359717C2 |
| RETARD TABLETS OF TRIMEBUTINE | 2013 |
|
RU2536254C1 |
